To further assess the impact of different p53 variants on cGAS-STING pathway activation under isogenic conditions, we first depleted mutp53-R273C expression in C33A cervical carcinoma cells6 and subsequently reconstituted with either WT, R175H, or R273H variant p53. The gene discussed is TP53; the disease is cervical carcinoma.